Xcout Intel
Manus Bio Inc.
Manus Bio Inc. uses industrial fermentation and bio-manufacturing technology to produce natural ingredients as alternatives to petroleum-derived and scarce products.
Subscribe to see Manus Bio Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Manus Bio Inc. at a glance
Manus Bio Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $11.3M in April 2024. Xcout tracks 14 named people at Manus Bio Inc., including Baljit Singh Ghotra (Chief Operating Officer).
Manus Bio Inc. leadership
- Baljit Singh GhotraChief Operating Officer
- Julio Ruiz CalderonChief Financial Officer
- Christine SantosChief Technology Officer
- Aji ParayilFounder and Chief Executive Officer
- Ajikumar Aji ParayilFounder and Chief Executive Officer
- Greg StephanopoulosFounder
8 more named people on record for Manus Bio Inc., with roles, board committees and tenure — see the full roster →
Manus Bio Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $11.3M | — | |
| SEC Form D filing | $21.2M | — | |
| Series B | $75M | 2 named | |
| SEC Form D filing | $66.2M | — | |
| SEC Form D filing | $10M | — | |
| SEC Form D filing | $9.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Manus Bio Inc. competitors
A few of Manus Bio Inc.'s closest competitors — see the full list of competitors and alternatives →
Amyris, Inc. is a vertically integrated biomanufacturing company that converts plant sugars into hydrocarbon molecules, specialty ingredients, and consumer products using precision fermentation.
Fermelanta, Inc. is a Japan-based biomanufacturing startup headquartered in Nonoichi, Ishikawa, that develops sustainable fermentation platforms utilizing microbes to replace petrochemical processes.
Saku Biosciences is an early-stage life sciences company founded in 2024 to improve the economics of biomanufacturing. The firm develops high-performance host cell products designed to advance biological manufacturing processes and therapeutic production. It operates out of Los Angeles, California, with a small team of approximately 8 employees.
Anomaly Bio is a Singapore-based company founded in 2025 that develops next-generation biomanufacturing techniques through engineered microbes. The company focuses on innovative biomanufacturing solutions, expanding its R&D team and laboratory facilities in Singapore.
Bloom Labs Bio Inc. specializes in the development and manufacturing of biologics, biosimilars, recombinant proteins, monoclonal antibodies, prebiotics, and probiotics. Utilizing modern biotechnology platforms and advanced infrastructure, the company serves the pharmaceutical and life sciences sectors with therapeutic and health and wellness solutions.
Get Manus Bio Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Manus Bio Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Manus Bio Inc. in Xcout Intel
- 14 named people with titles, LinkedIn and board committees
- 6 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access